H25
Conditions
Interventions
Group 1: There is only one observation group.
Every test subject performs tests with all 3 IOLs.
The test subjects are recruited via Probando, an online platform for recruiting study participants. Su
Sponsors
ACMIT Gmbh
Eligibility
Sex/Gender
All
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: • Refraction: Sphere (Sph): between -3 dpt and +3 dpt • Refraction: Cylinder (Cyl): = 1 decimal (or <= 0 logMAR) • After the medical examination, the subject was found suitable to receive cyclopentolate eye drops. • Informed and signed consent to participate in the study
Exclusion criteria
Exclusion criteria: • Diseases that affect visual acuity (glaucoma, cataract, AMD, corneal opacity or other retinal diseases) • Irregular astigmatism • Previous eye surgery of any kind • In women: pregnancy or breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This is an experimental observational study with an open outcome regarding the evaluation. The following parameters are tested: • Visual acuity in FAR, INTER, NEAR distances • Contrast sensitivity in FAR, INTER, NEAR distance • Visual acuity defocus curves (0.5 dpt step size, +1 dpt to -4 dpt) • Halo test in FAR • Subjective preference tests in FAR, INTER, NEAR distance | — |
Countries
Austria
Contacts
Public ContactGünal Kahraman
Akademisches Lehrkrankenhaus der Barmherzigen Brüder (Abteilung für Augenheilkunde)
Outcome results
None listed